Aim:The aim was to study the distribution of causes in nongravid women of reproductive age-group having abnormal uterine bleeding (AUB) as per the new International Federation of Gynecology and Obstetrics (FIGO) polyp; adenomyosis; leiomyoma; malignancy and hyperplasia; coagulopathy; ovulatory dysfunction; endometrial; iatrogenic; and not yet classified-(PALM-COEIN) classification system and to evaluate the practical applicability of this classification system in the clinical scenario. Materials and methods: A prospective cross-sectional study was conducted among 300 women with AUB attending the outpatient department of gynecology, selected by the kth random sampling technique. The etiological diagnosis was made in the PALM-COEIN spectrum. The practical applicability of the AUB-FIGO classification system was assessed by the survey of clinicians with help of a scoring system. Results: The majority of the study subjects were from 40 to 55 years age group with the median age of the study subjects being 42 years. Fifty-two subjects had two attributable causes from PALM-COEIN for AUB. In our study, 45% of subjects had leiomyoma, which turned out to be the most common etiology for AUB, and hypothyroidism was the most common endocrinopathy associated with 10% of AUB cases. Hysteroscopy was required to diagnose one case of amenorrhea. The clinician survey emphasized the high practical applicability of PALM-COEIN classification. Conclusion:The data generated from the clinical settings with this classification could be more comparable due to homogeneity and consistency in nomenclature. Clinical significance: The International Federation of Gynecology and Obstetrics classification for AUB is a clinician-friendly modality providing an easy algorithm for accurate diagnosis and definitive treatment of AUB.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.